HealthQuill Seagen
The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond the chemotherapy stage.
Drugs Health Pharma

Pfizer gets full US regulatory approval for cervical cancer drug

HQ Team April 30, 2024: The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond.

Read More
Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring its business and management.
Drugs Health Pharma

Pfizer revamps organisation as $43 billion Seagen deal comes to close

HQ Team December 13, 2023: Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring.

Read More
Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a company statement.
Drugs Health Medical Pharma

Pfizer to raise $31 billion in long-term debt for Seagen acquisition

HQ Team May 18, 2023: Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a.

Read More
X